Farther Finance Advisors, LLC Fibrogen Inc Call Options Transaction History
Farther Finance Advisors, LLC
- $5 Trillion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding FGEN
# of Institutions
14Shares Held
4.26MCall Options Held
35KPut Options Held
0-
Black Rock Inc. New York, NY2.41MShares$22.3 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.37MShares$12.7 Million0.0% of portfolio
-
Ci Private Wealth, LLC Miami, FL102KShares$944,4520.0% of portfolio
-
Morgan Stanley New York, NY97.7KShares$904,1320.0% of portfolio
-
Intercontinental Wealth Advisors, LLC95.7KShares$884,7620.06% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $867M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...